Ovarian cancer is number 8 of the top 10 cancers afflicting women across the US, according to the Centers for Disease Control and Prevention’s 2006 statistics. That means that in 2006, over 12 women of every 100,000 were diagnosed with ovarian cancer all over the world.
Those afflicted with ovarian cancer might have had a better chance had it been caught earlier and now there are studies to prove a new screening method does 99.9 percent of the time with few false positives.
This method, called The Risk of Ovarian Cancer Algorithm or ROCA, uses the CA-125 type of blood testing trends combined with pre-menopausal woman’s average age.
The author of the study, Karen Lu, MD, stated that only two cases were not reported and these two were borderline, meaning they may or may have not been cancerous. Every other case of the ovarian cancer was caught, no matter what stage it was at.
Better Chances of Detection
This is a major advance because the rate at which ovarian cancer is detected now, of most cases are in too an advanced stage to treat and 90 percent of these cases are terminal. With this new screening method, even the earliest cases can be detected, should it be approved for use by the FDA.
However, this screening is not to be used in daily practice just yet; there is currently a trial being conducted in the US, which includes 200,000 women. This study will not be concluded until at least 2015, when the results will be analyzed and the findings prepared for further testing if necessary.